Apeloa Pharmaceutical Co.,Ltd

SZSE:000739 Stock Report

Market Cap: CN¥17.6b

Apeloa PharmaceuticalLtd Future Growth

Future criteria checks 1/6

Apeloa PharmaceuticalLtd is forecast to grow earnings and revenue by 16.9% and 11.8% per annum respectively. EPS is expected to grow by 16.8% per annum. Return on equity is forecast to be 17.6% in 3 years.

Key information

16.9%

Earnings growth rate

16.8%

EPS growth rate

Pharmaceuticals earnings growth19.4%
Revenue growth rate11.8%
Future return on equity17.6%
Analyst coverage

Good

Last updated02 Sep 2024

Recent future growth updates

Recent updates

Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E

Aug 07
Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E

Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Jun 24
Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

May 08
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Earnings and Revenue Growth Forecasts

SZSE:000739 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202616,0631,6481,8071,9705
12/31/202514,5461,4011,5821,7336
12/31/202412,9021,1912031,6436
6/30/202411,9481,0796361,270N/A
3/31/202411,5871,0604541,089N/A
12/31/202311,4741,0554011,031N/A
9/30/202311,4941,1837841,304N/A
6/30/202311,5141,1531,3831,740N/A
3/31/202311,5291,0768991,377N/A
1/1/202310,5459898171,326N/A
9/30/202210,094851326822N/A
6/30/20229,651839-140617N/A
3/31/20229,077890-160635N/A
1/1/20228,943956-90612N/A
9/30/20218,468949-35722N/A
6/30/20218,165941180738N/A
3/31/20218,1468796751,048N/A
12/31/20207,8808177421,060N/A
9/30/20207,6067521,1561,276N/A
6/30/20207,6537021,4191,471N/A
3/31/20207,2365981,2821,340N/A
12/31/20197,2115531,3281,360N/A
9/30/20197,1225291,2581,316N/A
6/30/20196,8554659661,029N/A
3/31/20196,605414714811N/A
12/31/20186,376371751833N/A
9/30/20186,246367433523N/A
6/30/20185,882313258425N/A
3/31/20185,674275N/A410N/A
12/31/20175,552257N/A210N/A
9/30/20175,313253N/A465N/A
6/30/20175,312279N/A307N/A
3/31/20175,112274N/A304N/A
12/31/20164,772263N/A180N/A
9/30/20164,476201N/A223N/A
6/30/20164,349190N/A304N/A
3/31/20164,284198N/A255N/A
12/31/20154,338208N/A441N/A
9/30/20154,195231N/A580N/A
6/30/20154,219236N/A642N/A
3/31/20154,281241N/A750N/A
12/31/20144,233322N/A787N/A
9/30/20144,112313N/A435N/A
6/30/20144,100305N/A391N/A
3/31/20143,991274N/A198N/A
12/31/20133,855167N/A190N/A
9/30/20133,893169N/A226N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000739's forecast earnings growth (16.9% per year) is above the savings rate (2.9%).

Earnings vs Market: 000739's earnings (16.9% per year) are forecast to grow slower than the CN market (23.1% per year).

High Growth Earnings: 000739's earnings are forecast to grow, but not significantly.

Revenue vs Market: 000739's revenue (11.8% per year) is forecast to grow slower than the CN market (13.3% per year).

High Growth Revenue: 000739's revenue (11.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000739's Return on Equity is forecast to be low in 3 years time (17.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y